QIAGEN announced that its NeuMoDx human immunodeficiency virus type 1 (HIV-1) assay has received approval for use in Thailand. Along with the previously approved hepatitis B virus (HBV) and hepatitis C virus (HCV) quantitative assays there is now a full complement of blood-borne virus (BBV) assays available in Thailand. Every day, millions of patients infected […]

The post QIAGEN receives approval for NeuMoDx HIV-1 Quant assay in Thailand for blood-borne virus testing first appeared on World Pharma Today.